Readdi

- Readdi's standing has risen in the global pandemic preparedness community by leading a newly formed therapeutics development coalition. Readdi is collaborating with the international pandemic preparedness coalition, unitaid, drugs for neglected diseases (dndi) and the intrepid alliance to coordinate and accelerate the discovery and development of antiviral therapeutics for acute and endemic viral diseases that have the potential to become pandemics.- in conjunction with the therapeutics development coalition, Readdi is fostering relationships with global healthcare leaders interested in supporting development of therapeutics for infectious diseases.- Readdi authored or co-authored several published articles on the necessity of antiviral drug development that were well received by the global community.- Readdi's global network of collaborators has grown from approximately 30 institutions to approximately 65. - Readdi's potential pipeline of drug hits, leads and candidates has grown to approximately 30 active projects that we are closely monitoring for in-licensing opportunities.